Role of supraceliac aortic bypass in visceral artery reconstruction

A S Hermreck1, J H Thomas, J I Ilipoulos

  • 1Department of Surgery, University of Kansas Medical Center, Kansas City 66103.

Insights

Transabdominal, supraceliac aortomesenteric bypass effectively treats celiac and superior mesenteric artery occlusive disease. This visceral revascularization procedure demonstrates safety and efficacy in patients with intestinal ischemia and other complex vascular conditions.

Area of Science:

  • Vascular Surgery
  • Gastrointestinal Surgery
  • Abdominal Aortic Surgery

Background:

  • Celiac and superior mesenteric artery occlusive disease can lead to severe intestinal ischemia.
  • Surgical revascularization is a critical treatment option for these conditions.
  • Transabdominal, supraceliac bypass offers a potential approach for visceral artery reconstruction.

Purpose of the Study:

  • To evaluate the safety and efficacy of transabdominal, supraceliac aortomesenteric bypass.
  • To assess outcomes in patients undergoing this procedure for various indications, including intestinal ischemia.

Main Methods:

  • Twelve patients underwent transabdominal, supraceliac aortomesenteric bypass.
  • Procedures included aortoceliac, aortohepatic, and aortosuperior mesenteric artery bypasses, primarily using prosthetic grafts.
  • Indications included intestinal ischemia (acute and chronic), arcuate ligament syndrome, thoracoabdominal aneurysm, and infected aortic stump blowout.

Main Results:

  • One perioperative death occurred in a patient with severe comorbidities.
  • One graft thrombosis requiring revision was noted during a mean follow-up of 26 months.
  • The procedure was generally safe and effective for visceral revascularization.

Conclusions:

  • Transabdominal, supraceliac aortomesenteric bypass is a viable and effective surgical option.
  • It provides successful visceral revascularization for patients with complex aortomesenteric disease and associated complications.